Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Moretta, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 127 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Andre, P; Biassoni, R; Colonna, M; Cosman, D; Lanier, LL; Long, EO; Lopez-Botet, M; Moretta, A; Moretta, L; Parham, P; Trowsdale, J; Vivier, E; Wagtmann, N; Wilson, MJ
      New nomenclature for MHC receptors

      NATURE IMMUNOLOGY
    2. Moretta, A; Bottino, C; Vitale, M; Pende, D; Cantoni, C; Mingari, MC; Biassoni, R; Moretta, L
      Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis

      ANNUAL REVIEW OF IMMUNOLOGY
    3. Moretta, A; Maccario, R; Fagioli, F; Giraldi, E; Busca, A; Montagna, D; Miniero, R; Comoli, P; Giorgiani, G; Zecca, M; Pagani, S; Locatelli, F
      Analysis of immune reconstitution in children undergoing cord blood transplantation

      EXPERIMENTAL HEMATOLOGY
    4. Comoli, P; Locatelli, F; Moretta, A; Montagna, D; Calcaterra, V; Cometa, A; Basso, S; Zecca, M; Maccario, R
      Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses

      BONE MARROW TRANSPLANTATION
    5. Biassoni, R; Cantoni, C; Pende, D; Sivori, S; Parolini, S; Vitale, M; Bottino, C; Moretta, A
      Human natural killer cell receptors and co-receptors

      IMMUNOLOGICAL REVIEWS
    6. Moretta, L; Biassoni, R; Bottino, C; Mingari, MC; Moretta, A
      Immunobiology of human NK cells

      TRANSPLANTATION PROCEEDINGS
    7. Vely, F; Peyrat, MA; Couedel, C; Morcet, JF; Halary, F; Davodeau, F; Romagne, F; Scotet, E; Saulquin, X; Houssaint, E; Schleinitz, N; Moretta, A; Vivier, E; Bonneville, M
      Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements

      JOURNAL OF IMMUNOLOGY
    8. Bottino, C; Falco, M; Parolini, S; Marcenaro, E; Augugliaro, R; Sivori, S; Landi, E; Biassoni, R; Notarangelo, LD; Moretta, L; Moretta, A
      GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease

      JOURNAL OF EXPERIMENTAL MEDICINE
    9. Pende, D; Cantoni, C; Rivera, P; Vitale, M; Castriconi, R; Marcenaro, S; Nanni, M; Biassoni, R; Bottino, C; Moretta, A; Moretta, L
      Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors ofnonepithelial origin

      EUROPEAN JOURNAL OF IMMUNOLOGY
    10. Vitale, M; Falco, M; Castriconi, R; Parolini, S; Zambello, R; Semenzato, G; Biassoni, R; Bottino, C; Moretta, L; Moretta, A
      Identification of NKp80, a novel triggering molecule expressed by human NKcells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    11. Gati, A; Guerra, N; Giron-Michel, J; Azzarone, B; Angevin, E; Moretta, A; Chouaib, S; Caignard, A
      Tumor cells regulate the lytic activity of tumor-specific cytotoxic T lymphocytes by modulating the inhibitory natural killer receptor function

      CANCER RESEARCH
    12. Montagna, D; Maccario, R; Locatelli, F; Rosti, V; Yang, Y; Farness, P; Moretta, A; Comoli, P; Montini, E; Vitiello, A
      Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy

      BLOOD
    13. Bagot, M; Moretta, A; Sivori, S; Biassoni, R; Cantoni, C; Bottino, C; Boumsell, L; Bensussan, A
      CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor

      BLOOD
    14. Moretta, A; Biassoni, R; Bottino, C; Moretta, L
      Surface receptors delivering opposite signals regulate the function of human NK cells

      SEMINARS IN IMMUNOLOGY
    15. Sivori, S; Parolini, S; Marcenaro, E; Millo, R; Bottino, C; Moretta, A
      Triggering receptors involved in natural killer cell-mediated cytotoxicityagainst choriocarcinoma cell lines

      HUMAN IMMUNOLOGY
    16. Bottino, C; Biassoni, R; Millo, R; Moretta, L; Moretta, A
      The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering

      HUMAN IMMUNOLOGY
    17. Moretta, L; Biassoni, R; Bottino, C; Mingari, MC; Moretta, A
      Human NK-cell receptors

      IMMUNOLOGY TODAY
    18. Colonna, M; Moretta, A; Vely, F; Vivier, E
      A high-resolution view of NK-cell receptors: structure and function

      IMMUNOLOGY TODAY
    19. Moretta, A; Biassoni, R; Bottino, C; Mingari, MC; Moretta, L
      Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis

      IMMUNOLOGY TODAY
    20. Moretta, L; Moretta, A; Hengartner, H; Zinkernagel, RM
      On the pathogenesis of perforin defects and related immunodeficiencies

      IMMUNOLOGY TODAY
    21. Sivori, S; Parolini, S; Marcenaro, E; Castriconi, R; Pende, D; Millo, R; Moretta, A
      Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines

      JOURNAL OF NEUROIMMUNOLOGY
    22. Biassoni, R; Cantoni, C; Falco, M; Pende, D; Millo, R; Moretta, L; Bottino, C; Moretta, A
      Human natural killer cell activating receptors

      MOLECULAR IMMUNOLOGY
    23. Parolini, S; Bottino, C; Falco, M; Augugliaro, R; Giliani, S; Franceschini, R; Ochs, HD; Wolf, H; Bonnefoy, JY; Biassoni, R; Moretta, L; Notarangelo, LD; Moretta, A
      X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

      JOURNAL OF EXPERIMENTAL MEDICINE
    24. Jabri, B; De Serre, NPM; Cellier, C; Evans, K; Gache, C; Carvalho, C; Mougenot, JF; Allez, M; Jian, R; Desreumaux, P; Colombel, JF; Matuchansky, C; Cugnenc, H; Lopez-Botet, M; Vivier, E; Moretta, A; Roberts, AI; Ebert, EC; Guy-Grand, D; Brousse, N; Schmitz, J; Cerf-Bensussan, N
      Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease

      GASTROENTEROLOGY
    25. D'Andrea, A; Goux, D; De Lalla, C; Koezuka, Y; Montagna, D; Moretta, A; Dellabona, P; Casorati, G; Abrignani, S
      Neonatal invariant V alpha 24(+) NKT lymphocytes are activated memory cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    26. Sivori, S; Parolini, S; Falco, M; Marcenaro, E; Biassoni, R; Bottino, C; Moretta, L; Moretta, A
      2B4 functions as a co-receptor in human NK cell activation

      EUROPEAN JOURNAL OF IMMUNOLOGY
    27. Bottino, C; Falco, M; Sivori, S; Moretta, L; Moretta, A; Biassoni, R
      Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering

      EUROPEAN JOURNAL OF IMMUNOLOGY
    28. Bottino, C; Augugliaro, R; Castriconi, R; Nanni, M; Biassoni, R; Moretta, L; Moretta, A
      Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    29. Guerra, N; Guillard, M; Angevin, E; Echchakir, H; Escudier, B; Moretta, A; Chouaib, S; Caignard, A
      Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas

      BLOOD
    30. Biassoni, R; Bottino, C; Millo, R; Moretta, L; Moretta, A
      Natural killer cell-mediated recognition of human trophoblast

      SEMINARS IN CANCER BIOLOGY
    31. Vitale, M; Castriconi, R; Parolini, S; Pende, D; Hsu, ML; Moretta, L; Cosman, D; Moretta, A
      The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LID-1(+) NK cell clones

      INTERNATIONAL IMMUNOLOGY
    32. Bozzola, M; Radetti, G; Buzi, F; Tonini, G; Moretta, A; Autelli, M; Aglialoro, A; Rondini, G; Barreca, A
      Growth hormone bioactivity and immunoactivity in tall children

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    33. Moretta, A; Locatelli, F; Mingrat, G; Rondini, G; Montagna, D; Comoli, P; Gandossini, S; Montini, E; Labirio, M; Maccario, R
      Characterisation of CTL directed towards non-inherited maternal alloantigens in human cord blood

      BONE MARROW TRANSPLANTATION
    34. Falco, M; Cantoni, C; Bottino, C; Moretta, A; Biassoni, R
      Identification of the rat homologue of the human NKp46 triggering receptor

      IMMUNOLOGY LETTERS
    35. Cantoni, C; Falco, M; Pessino, A; Moretta, A; Moretta, L; Biassoni, R
      p49, a putative HLA-G1-specific inhibitory NK receptor belonging to the Immunoglobulin Superfamily

      JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    36. Castellazzi, AM; Maccario, R; Moretta, A; De Amici, M; Gasparoni, A; Chirico, G; Rondini, G
      Effect of active and passive smoking during pregnancy on natural killer-cell activity in infants

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    37. Moretta, A; Bottino, C; Millo, R; Biassoni, R
      HLA-Specific and non-HLA-specific human NK receptors

      IMMUNORECEPTOR TYROSINE-BASED INHIBITION MOTIFS
    38. Vitale, C; Romagnani, C; Falco, M; Ponte, M; Vitale, M; Moretta, A; Bacigalupo, A; Moretta, L; Mingari, MC
      Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    39. Ponte, M; Cantoni, C; Biassoni, R; Tradori-Cappai, A; Bentivoglio, G; Vitale, C; Bertone, S; Moretta, A; Moretta, L; Mingari, MC
      Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    40. Falco, M; Biassoni, R; Bottino, C; Vitale, M; Sivori, S; Augugliaro, R; Moretta, L; Moretta, A
      Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells

      JOURNAL OF EXPERIMENTAL MEDICINE
    41. Pende, D; Parolini, S; Pessino, A; Sivori, S; Augugliaro, R; Morelli, L; Marcenaro, E; Accame, L; Malaspina, A; Biassoni, R; Bottino, C; Moretta, L; Moretta, A
      Identification and molecular characterization of NKp30, a novel triggeringreceptor involved in natural cytotoxicity mediated by human natural killercells

      JOURNAL OF EXPERIMENTAL MEDICINE
    42. Cantoni, C; Bottino, C; Vitale, M; Pessino, A; Augugliaro, R; Malaspina, A; Parolini, S; Moretta, L; Moretta, A; Biassoni, R
      NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

      JOURNAL OF EXPERIMENTAL MEDICINE
    43. Sivori, S; Pende, D; Bottino, C; Marcenaro, E; Pessino, A; Biassoni, R; Moretta, L; Moretta, A
      NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    44. Zimmer, J; Donato, L; Hanau, D; Cazenave, JP; Moretta, A; Tongio, MM; de la Salle, H
      Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression

      EUROPEAN JOURNAL OF IMMUNOLOGY
    45. Biassoni, R; Pessino, A; Bottino, C; Pende, D; Moretta, L; Moretta, A
      The murine homologue of the human NKp46, a triggering receptor involved inthe induction of natural cytotoxicity

      EUROPEAN JOURNAL OF IMMUNOLOGY
    46. Cantoni, C; Bottino, C; Augugliaro, R; Morelli, L; Marcenaro, E; Castriconi, R; Vitale, M; Pende, D; Sivori, S; Millo, R; Biassoni, R; Moretta, L; Moretta, A
      Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells

      EUROPEAN JOURNAL OF IMMUNOLOGY
    47. De Amici, D; Gasparoni, A; Chirico, G; Ceriana, P; Bartoli, A; Ramajoli, I; Moretta, A
      Natural killer cell activity and delivery: Possible influence of cortisol and anesthetic agents - A study on newborn cord blood

      BIOLOGY OF THE NEONATE
    48. Birolo, L; Malashkevich, VN; Capitani, G; De Luca, F; Moretta, A; Jansonius, JN; Marino, G
      Functional and structural analysis of cis-proline mutants of Escherichia coli aspartate aminotransferase

      BIOCHEMISTRY
    49. MONTAGNA D; LOCATELLI F; CALCATERRA V; COMOLI P; MORETTA A; GIORGIANI G; ZECCA M; BONETTI F; GIRALDI E; RONDINI G; MACCARIO R
      DOES THE EMERGENCE AND PERSISTENCE OF DONOR-DERIVED LEUKEMIA-REACTIVECYTOTOXIC T-LYMPHOCYTES PROTECT PATIENTS GIVEN AN ALLOGENEIC BMT FROMRECURRENCE - RESULTS OF A PRELIMINARY-STUDY

      Bone marrow transplantation
    50. MONTAGNA D; LOCATELLI F; CALCATERRA V; COMOLI P; MORETTA A; GIORGIANI G; BONETTI F; ZECCA M; MACCARIO R
      LEUKEMIA-SPECIFIC CTLP IN CHILDREN WITH LEUKEMIA GIVEN ALLOGENEIC OR AUTOLOGOUS BMT - A USEFUL TOOL TO PREDICT THE PERSISTENCE OF HEMATOLOGICAL REMISSION

      Bone marrow transplantation
    51. COMOLI P; LOCATELLI F; MONTAGNA D; CALCATERRA V; MORETTA A; GIORGIANI G; BONETTI F; ZECCA M; MACCARIO R
      INDUCTION OF ALLOANTIGEN-SPECIFIC ANERGY DOES NOT IMPAIR CYTOLYTIC ACTIVITY OF LEUKEMIA-REACTIVE HUMAN T-CELLS

      Bone marrow transplantation
    52. BELLONI C; TINELLI C; ORSOLINI P; PISTORIO A; AVANZINI A; MORETTA A; GULMINETTI R; BOGLIOLO O; CHIRICO G; RONDINI G
      REVACCINATION AGAINST HEPATITIS-B VIRUS OF NON-RESPONDING AND LOW-RESPONDING INFANTS IMMUNIZED AT BIRTH - A PARALLEL EVALUATION OF RUBELLA AND TETANUS VACCINE

      Vaccine
    53. POCCIA F; GOUGEON ML; BONNEVILLE M; LOPEZBOTET M; MORETTA A; BATTISTINI L; WALLACE M; COLIZZI V; MALKOVSKY M
      INNATE T-CELL IMMUNITY TO NONPEPTIDIC ANTIGENS

      Immunology today
    54. MINGARI MC; MORETTA A; MORETTA L
      REGULATION OF KIR EXPRESSION IN HUMAN T-CELLS - A SAFETY MECHANISM THAT MAY IMPAIR PROTECTIVE T-CELL RESPONSES

      Immunology today
    55. MINGARI MC; PONTE M; BERTONE S; SCHIAVETTI F; VITALE C; BELLOMO R; MORETTA A; MORETTA L
      HLA CLASS I-SPECIFIC INHIBITORY RECEPTORS IN HUMAN T-LYMPHOCYTES - INTERLEUKIN 15-INDUCED EXPRESSION OF CD94 NKG2A IN SUPERANTIGEN-ACTIVATED OR ALLOANTIGEN-ACTIVATED CD8(+) T-CELLS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    56. PESSINO A; SIVORI S; BOTTINO C; MALASPINA A; MORELLI L; MORETTA L; BIASSONI R; MORETTA A
      MOLECULAR-CLONING OF NKP46 - A NOVEL MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY INVOLVED IN TRIGGERING OF NATURAL CYTOTOXICITY

      The Journal of experimental medicine
    57. VITALE M; BOTTINO C; SIVORI S; SANSEVERINO L; CASTRICONI R; MARCENARO E; AUGUGLIARO R; MORETTA L; MORETTA A
      NKP44, A NOVEL TRIGGERING SURFACE-MOLECULE SPECIFICALLY EXPRESSED BY ACTIVATED NATURAL-KILLER-CELLS, IS INVOLVED IN NONMAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED TUMOR-CELL LYSIS

      The Journal of experimental medicine
    58. ZIMMER J; DONATO L; HANAU D; CAZENAVE JP; TONGIO MM; MORETTA A; DELASALLE H
      ACTIVITY AND PHENOTYPE OF NATURAL-KILLER-CELLS IN PEPTIDE TRANSPORTER(TAP)-DEFICIENT PATIENTS (TYPE-I BARE LYMPHOCYTE SYNDROME)

      The Journal of experimental medicine
    59. PENDE D; ACCAME L; PARETI L; MAZZOCCHI A; MORETTA A; PARMIANI G; MORETTA L
      THE SUSCEPTIBILITY TO NATURAL-KILLER CELL-MEDIATED LYSIS OF HLA CLASSI-POSITIVE MELANOMAS REFLECTS THE EXPRESSION OF INSUFFICIENT AMOUNTS OF DIFFERENT HLA CLASS-I ALLELES

      European Journal of Immunology
    60. LEDREAN E; VELY F; OLCESE L; CAMBIAGGI A; GUIA S; KRYSTAL G; GERVOIS N; MORETTA A; JOTEREAU J; VIVIER E
      INHIBITION OF ANTIGEN-INDUCED T-CELL RESPONSE AND ANTIBODY-INDUCED NKCELL CYTOTOXICITY BY NKG2A - ASSOCIATION OF NKG2A WITH SHP-1 AND SHP-2 PROTEIN-TYROSINE PHOSPHATASES (VOL 28, PG 264, 1998)

      European Journal of Immunology
    61. LEDREAN E; VELY F; OLCESE L; CAMBIAGGI A; GUIA S; KRYSTAL G; GERVOIS N; MORETTA A; JOTEREAU F; VIVIER E
      INHIBITION OF ANTIGEN-INDUCED T-CELL RESPONSE AND ANTIBODY-INDUCED NKCELL CYTOTOXICITY BY NKG2A - ASSOCIATION OF NKG2A WITH SHP-1 AND SHP-2 PROTEIN-TYROSINE PHOSPHATASES

      European Journal of Immunology
    62. CANTONI C; BIASSONI R; PENDE D; SIVORI S; ACCAME L; PARETI L; SEMENZATO G; MORETTA L; MORETTA A; BOTTINO C
      THE ACTIVATING FORM OF CD94 RECEPTOR COMPLEX - CD94 COVALENTLY ASSOCIATES WITH THE KP39 PROTEIN THAT REPRESENTS THE PRODUCT OF THE NKG2-C GENE

      European Journal of Immunology
    63. IKEDA H; LETHE B; LEHMANN F; VANBAREN N; BAURAIN JF; DESMET C; CHAMBOST H; VITALE M; MORETTA A; BOON T; COULIE PG
      CHARACTERIZATION OF AN ANTIGEN THAT IS RECOGNIZED ON A MELANOMA SHOWING PARTIAL HLA LOSS BY CTL EXPRESSING AN NK INHIBITORY RECEPTOR

      Immunity
    64. MORETTA A; PAROLINI S; CASTRICONI R; BOTTINO C; VITALE M; SIVORI S; MILLO R
      FUNCTION AND SPECIFICITY OF HUMAN NATURAL-KILLER-CELL RECEPTORS

      European journal of immunogenetics
    65. MORETTA A; MORETTA L
      HLA CLASS-I SPECIFIC INHIBITORY RECEPTORS

      Current opinion in immunology
    66. BOZZOLA M; MORETTA A; PAGANI S; RAPAPORT RG
      EFFECTS OF GROWTH-HORMONE ON NATURAL-KILLER-CELLS

      Acta paediatrica
    67. MORETTA A; BIASSONI R; BOTTINO C; PENDE D; VITALE M; POGGI A; MINGARI MC; MORETTA L
      MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-SPECIFIC RECEPTORS ON HUMAN NATURAL-KILLER AND T-LYMPHOCYTES

      Immunological reviews
    68. MORETTA A
      MOLECULAR MECHANISMS IN CELL-MEDIATED CYTOTOXICITY

      Cell
    69. CAMBIAGGI A; VERTHUY C; NAQUET P; ROMAGNE F; FERRIER P; BIASSONI R; MORETTA A; MORETTA L; VIVIER E
      NATURAL-KILLER-CELL ACCEPTANCE OF H2 MISMATCH BONE-MARROW GRAFTS IN TRANSGENIC MICE EXPRESSING HLA-CW3 SPECIFIC KILLER-CELL INHIBITORY RECEPTOR (CD158B)

      Proceedings of the National Academy of Sciences of the United Statesof America
    70. OLCESE L; CAMBIAGGI A; SEMENZATO G; BOTTINO C; MORETTA A; VIVIER E
      HUMAN KILLER-CELL ACTIVATORY RECEPTORS FOR MHC CLASS-I MOLECULES ARE INCLUDED IN A MULTIMERIC COMPLEX EXPRESSED BY NATURAL-KILLER-CELLS

      The Journal of immunology
    71. SIVORI S; VITALE M; MORELLI L; SANSEVERINO L; AUGUGLIARO R; BOTTINO C; MORETTA L; MORETTA A
      P46, A NOVEL NATURAL-KILLER CELL-SPECIFIC SURFACE-MOLECULE THAT MEDIATES CELL ACTIVATION

      The Journal of experimental medicine
    72. DEBENEDETTI F; ALONZI T; MORETTA A; LAZZARO D; COSTA P; POLI V; MARTINI A; CILIBERTO G; FATTORI E
      INTERLEUKIN-6 CAUSES GROWTH IMPAIRMENT IN TRANSGENIC MICE THROUGH A DECREASE IN INSULIN-LIKE GROWTH-FACTOR-I - A MODEL FOR STUNTED GROWTH IN CHILDREN WITH CHRONIC INFLAMMATION

      The Journal of clinical investigation
    73. BLERY M; DELON J; TRAUTMANN A; CAMBIAGGI A; OLCESE L; BIASSONI R; MORETTA L; CHAVRIER P; MORETTA A; DAERON M; VIVIER E
      RECONSTITUTED KILLER-CELL INHIBITORY RECEPTORS FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES CONTROL MAST-CELL ACTIVATION-INDUCED VIA IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIFS

      The Journal of biological chemistry
    74. PENDE D; SIVORI S; ACCAME L; PARETI L; FALCO M; GERAGHTY D; LEBOUTEILLER P; MORETTA L; MORETTA A
      HLA-G RECOGNITION BY HUMAN NATURAL-KILLER-CELLS - INVOLVEMENT OF CD94BOTH AS INHIBITORY AND AS ACTIVATING RECEPTOR COMPLEX

      European Journal of Immunology
    75. VELY F; OLIVERO S; OLCESE L; MORETTA A; DAMEN JE; LIU L; KRYSTAL G; CAMBIER JC; DAERON M; VIVIER E
      DIFFERENTIAL ASSOCIATION OF PHOSPHATASES WITH HEMATOPOIETIC CO-RECEPTORS BEARING IMMUNORECEPTOR TYROSINE-BASED INHIBITION MOTIFS

      European Journal of Immunology
    76. MINGARI MC; VITALE C; CANTONI C; BELLOMO R; PONTE M; SCHIAVETTI F; BERTONE S; MORETTA A; MORETTA L
      INTERLEUKIN-15-INDUCED MATURATION OF HUMAN NATURAL-KILLER-CELLS FROM EARLY THYMIC PRECURSORS - SELECTIVE EXPRESSION OF CD94 NKG2-A AS THE ONLY HLA CLASS I-SPECIFIC INHIBITORY RECEPTOR/

      European Journal of Immunology
    77. CARRETERO M; CANTONI C; BELLON T; BOTTINO C; BIASSONI R; RODRIGUEZ A; PEREZVILLAR JJ; MORETTA L; MORETTA A; LOPEZBOTET M
      THE CD94 AND NKG2-A C-TYPE LECTINS COVALENTLY ASSEMBLE TO FORM A NATURAL-KILLER-CELL INHIBITORY RECEPTOR FOR HLA CLASS-I MOLECULES

      European Journal of Immunology
    78. BIASSONI R; PESSINO A; MALASPINA A; CANTONI C; BOTTINO C; SIVORI S; MORETTA L; MORETTA A
      ROLE OF AMINO-ACID POSITION-70 IN THE BINDING-AFFINITY OF P50.1 AND P58.1 RECEPTORS FOR HLA-CW4 MOLECULES

      European Journal of Immunology
    79. HALARY F; PEYRAT MA; CHAMPAGNE E; LOPEZBOTET M; MORETTA A; MORETTA L; VIE H; FOURNIE JJ; BONNEVILLE M
      CONTROL OF SELF-REACTIVE CYTOTOXIC T-LYMPHOCYTES EXPRESSING GAMMA-DELTA T-CELL RECEPTORS BY NATURAL-KILLER INHIBITORY RECEPTORS

      European Journal of Immunology
    80. MORETTA A; COMOLI P; MONTAGNA D; GASPARONI A; PERCIVALLE E; CARENA I; REVELLO MG; GERNA G; MINGRAT G; LOCATELLI F; RONDINI G; MACCARIO R
      HIGH-FREQUENCY OF EPSTEIN-BARR-VIRUS (EBV) LYMPHOBLASTOID CELL LINE-REACTIVE LYMPHOCYTES IN CORD-BLOOD - EVALUATION OF CYTOLYTIC ACTIVITY AND IL-2 PRODUCTION

      Clinical and experimental immunology
    81. COMOLI P; LOCATELLI F; MONTAGNA D; CALCATERRA V; MORETTA A; GIORGIANI G; BONETTI F; ZECCA M; MACCARIO R
      INDUCTION OF ALLOANTIGEN-SPECIFIC ANERGY DOES NOT IMPAIR CYTOLYTIC ACTIVITY OF LEUKEMIA-REACTIVE HUMAN T-CELLS

      Blood
    82. MAGHNIE M; MORETTA A; VALTORTA A; LARIZZA D; SAYEGH M; GRECO AM; CASTOLDI E; SEVERI F
      GROWTH-HORMONE RESPONSE TO GROWTH HORMONE-RELEASING HORMONE VARIES WITH THE HYPOTHALAMIC-PITUITARY ABNORMALITIES

      European journal of endocrinology
    83. MORETTA A; BOTTINO C; VITALE M; PENDE D; BIASSONI R; MINGARI MC; MORETTA L
      RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL-KILLER-CELLS

      Annual review of immunology
    84. MORETTA L; MINGARI MC; PENDE D; BOTTINO C; BIASSONI R; MORETTA A
      THE MOLECULAR-BASIS OF NATURAL-KILLER (NK) CELL RECOGNITION AND FUNCTION

      Journal of clinical immunology
    85. MONTAGNA D; MACCARIO R; COMOLI P; PRETE L; ZECCA M; GIRALDI E; DAIELLI C; MORETTA A; DESTEFANO P; LOCATELLI F
      FREQUENCY OF DONOR CYTOTOXIC T-CELL PRECURSORS DOES NOT CORRELATE WITH OCCURRENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE IN CHILDREN TRANSPLANTED USING UNRELATED DONORS

      Journal of clinical immunology
    86. SIVORI S; VITALE M; SANSEVERINO L; PAROLINI S; BARBARESI M; BOTTINO C; MORETTA A
      INHIBITORY CD94 MOLECULES IDENTIFIED BY THE Z199 MONOCLONAL-ANTIBODY RECOGNIZE DIFFERENT HLA-CLASS-I MOLECULES

      Transplantation proceedings
    87. VITALE M; SIVORI S; PENDE D; AUGUGLIARO R; DIDONATO C; AMOROSO A; MALNATI M; BOTTINO C; MORETTA L; MORETTA A
      PHYSICAL AND FUNCTIONAL INDEPENDENCY OF P70 AND P58 NATURAL-KILLER (NK) CELL RECEPTORS FOR HLA CLASS-I - THEIR ROLE IN THE DEFINITION OF DIFFERENT GROUPS OF ALLOREACTIVE NK CELL CLONES

      Proceedings of the National Academy of Sciences of the United Statesof America
    88. PEREZVILLAR JJ; CARRETERO M; NAVARRO F; MELERO I; RODRIGUEZ A; BOTTINO C; MORETTA A; LOPEZBOTET M
      BIOCHEMICAL AND SEROLOGIC EVIDENCE FOR THE EXISTENCE OF FUNCTIONALLY DISTINCT FORMS OF THE CD94 NK CELL-RECEPTOR

      The Journal of immunology
    89. VAVASSORI M; MACCARIO R; MORETTA A; COMOLI P; WACK A; LOCATELLI F; LANZAVECCHIA A; MASERATI E; DELLABONA P; CASORATI G; MONTAGNA D
      RESTRICTED TCR REPERTOIRE AND LONG-TERM PERSISTENCE OF DONOR-DERIVED ANTIGEN-EXPERIENCED CD4(-CELLS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION RECIPIENTS() T)

      The Journal of immunology
    90. OLCESE L; LANG P; VELY F; CAMBIAGGI A; MARGUET D; BLERY M; HIPPEN KL; BIASSONI R; MORETTA A; MORETTO L; CAMBIER JC; VIVIER E
      HUMAN AND MOUSE KILLER-CELL INHIBITORY RECEPTORS RECRUIT PTP1C AND PTPLD PROTEIN-TYROSINE PHOSPHATASES

      The Journal of immunology
    91. PENDE D; BIASSONI R; CANTONI C; VERDIANI S; FALCO M; DIDONATO C; ACCAME L; BOTTINO C; MORETTA A; MORETTA L
      THE NATURAL-KILLER-CELL RECEPTOR-SPECIFIC FOR HLA-A ALLOTYPES - A NOVEL MEMBER OF THE P58 P70 FAMILY OF INHIBITORY RECEPTORS THAT IS CHARACTERIZED BY 3 IMMUNOGLOBULIN-LIKE DOMAINS AND IS EXPRESSED AS A 140-KD DISULFIDE-LINKED DIMER/

      The Journal of experimental medicine
    92. BIASSONI R; CANTONI C; FALCO M; VERDIANI S; BOTTINO C; VITALE M; CONTE R; POGGI A; MORETTA A; MORETTA L
      THE HUMAN-LEUKOCYTE ANTIGEN (HLA)-C-SPECIFIC ACTIVATORY OR INHIBITORYNATURAL-KILLER-CELL RECEPTORS DISPLAY HIGHLY HOMOLOGOUS EXTRACELLULARDOMAINS BUT DIFFER IN THEIR TRANSMEMBRANE AND INTRACYTOPLASMIC PORTIONS

      The Journal of experimental medicine
    93. COULIE G; IKEDA H; MORETTA A; BOON T
      T-CELL RESPONSES AGAINST HLA-LOSS TUMOR-CELL VARIANTS

      Immunology
    94. BOTTINO C; SIVORI S; VITALE M; CANTONI C; FALCO R; PENDE D; MORELLI L; AUGUGLIARO R; SEMENZATO G; BIASSONI R; MORETTA L; MORETTA A
      A NOVEL SURFACE-MOLECULE HOMOLOGOUS TO THE P58 P50 FAMILY OF RECEPTORS IS SELECTIVELY EXPRESSED ON A SUBSET OF HUMAN NATURAL-KILLER-CELLS AND INDUCES BOTH TRIGGERING OF CELL FUNCTIONS AND PROLIFERATION/

      European Journal of Immunology
    95. SIVORI S; VITALE M; BOTTINO C; MARCENARO E; SANSEVERINO L; PAROLINI S; MORETTA L; MORETTA A
      CD94 FUNCTIONS AS A NATURAL-KILLER-CELL INHIBITORY RECEPTOR FOR DIFFERENT HLA CLASS-I ALLELES - IDENTIFICATION OF THE INHIBITORY FORM OF CD94 BY THE USE OF NOVEL MONOCLONAL-ANTIBODIES

      European Journal of Immunology
    96. MONTAGNA D; LOCATELLI F; BONETTI F; MORETTA A; COMOLI P; ZECCA M; CARRA AM; MACCARIO R
      ANTIGEN-EXPERIENCED T-CELL PRECURSORS RESIDE IN THE BONE-MARROW, ARE NOT AFFECTED BY CHEMOTHERAPY AND CAN BE TRANSFERRED WITH BMT

      Blood
    97. COMOLI P; LOCATELLI F; MONTAGNA D; MORETTA A; PERCIVALLE E; ZECCA M; DESTEFANO P; GIORGIANI G; LANZAVECCHIA A; MACCARIO R
      HUMAN-LYMPHOCYTES RENDERED NONRESPONSIVE TOWARDS ALLOANTIGENS BY A COMBINATION OF CTLA4-IG AND CYCLOSPORINE-A RETAIN THE CAPACITY TO DEVELOP VIRUS-SPECIFIC CYTOLYTIC ACTIVITY

      Blood
    98. DEBENEDETTI F; MORETTA A; MARTINI A
      IL-6 CAUSES STUNTED GROWTH IN TRANSGENIC MICE THROUGH A DECREASE IN INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) - A MODEL FOR STUNTED GROWTH IN CHILDREN WITH CHRONIC INFLAMMATION

      Arthritis and rheumatism
    99. WAGTMANN N; BIASSONI R; CANTONI C; VERDIANI S; MALNATI MS; VITALE M; BOTTINO C; MORETTA L; MORETTA A; LONG EO
      MOLECULAR CLONES OF THE P58 NK CELL-RECEPTOR REVEAL IMMUNOGLOBULIN-RELATED MOLECULES WITH DIVERSITY IN BOTH THE EXTRACELLULAR AND INTRACELLULAR DOMAINS

      Immunity
    100. CICCONE E; PENDE D; NANNI L; DIDONATO C; VIALE O; BERETTA A; VITALE M; SIVORI S; MORETTA A; MORETTA L
      GENERAL ROLE OF HLA CLASS-I MOLECULES IN THE PROTECTION OF TARGET-CELLS FROM LYSIS BY NATURAL-KILLER-CELLS - EVIDENCE THAT THE FREE HEAVY-CHAINS OF CLASS-I MOLECULES ARE NOT SUFFICIENT TO MEDIATE THE PROTECTIVE EFFECT

      International immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 04:09:28